T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma

NCT01946373 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: T cells
BIOLOGICAL: Interleukin-2
BIOLOGICAL: Dendritic cell vaccine

Sponsor

Karolinska University Hospital